Skip to content

Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System

Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02074761
Enrollment
250
Registered
2014-02-28
Start date
2015-01-06
Completion date
2020-11-30
Last updated
2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac Joint Dysfunction

Keywords

sacroiliac joint fusion, SIJ fusion, SI joint, SIJ

Brief summary

Sacroiliac joint pain reduction and radiographic evidence of SIJ fusion will be collected to evaluate clinical performance of the SImmetry Sacroiliac Joint Fusion System.

Detailed description

This is a prospective, non-randomized post market study designed to evaluate fusion and pain reduction following the use of the SImmetry System. This study will be conducted at up to 40 sites and 250 total subjects will be enrolled and followed through 24 months. Data will be collected pre-operatively, implant, and at specified follow-up time points through 24 months.

Interventions

DEVICESImmetry

The SImmetry device is commercially available. The implanted devices consist of a range of threaded, self-tapping, cannulated implants designed to transfix the sacrum and ilium, providing stability for intra-articular fusion. The SImmetry Surgical Instruments include standard manual surgical instruments used to access and prepare the sacroiliac joint space for intra-articular fusion.

Sponsors

Surgalign Spine Technologies
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * At least three positive provocative tests for SIJ pain * Non-operative management of SIJ pain for ≥ 6 months prior to surgery * At least one positive diagnostic SIJ injection resulting in a ≥ 50% decrease in pain * VAS back pain score of ≥ 60 mm * The subject is at least 18 years of age Key

Exclusion criteria

* Trauma causing fracture of the sacrum or iliac bones or has had spinal trauma leading to a neurological deficit, or pelvic soft tissue or bony tumors * Pregnant or is planning on becoming pregnant in the next two years * Chemical dependency abuse problems as evidenced by a history of abusing drugs which is documented in their past medical history or is elicited from an interview. * Receiving or seeking worker's compensation, disability remuneration, and/or involved in litigation related to low back or SIJ pain * History of significant emotional or psychosocial disturbance

Design outcomes

Primary

MeasureTime frameDescription
SI Joint Fusion12 monthsFusion of the SI joint at 12 and 24 months, defined as presence of a continuous segment of solid bridging bone that extends from the sacrum to the ilium. This will be assessed by an independent core laboratory
SI Joint Pain Reduction6 MonthsSI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to 6 months.

Secondary

MeasureTime frameDescription
SI Joint Pain Reduction12 monthsSI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to all follow-up visits.
Disability6 monthsFunctional ability as determined by the Oswestry Disability Index
Quality of Life6 monthsQuality of life as determined by EQ-5D

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026